BYSI

0.330024.49%
JM

Jiangwen Majeti

Independent Vice Chairman

Dr. Jiangwen Majeti, Ph.D., M.B.A., also known as Jen, is Independent Director of BeyondSpring Inc. from August 29, 2022 and as its Independent Vice Chairman from July 1, 2026. She is an investor, biotech company advisor and an executive with vast experience in the biotech and pharmaceutical industry. Most recently, she was the Head of Global Collaborations and General Manager, China of Erasca Inc. Prior to that, she was Global Category Leader for Roche External Alliance. She is the past president and currently serves on the board of directors of the Chinese-American Biopharmaceutical Society. She is also a member of the BayHelix Group. Dr. Majeti earned her Ph.D. from the University of Wisconsin at Madison and obtained her postdoctoral training at the Howard Hughes Medical Institute of the University of California, San Francisco. She also earned an MBA from the Leavey School of Business at Santa Clara University, graduating as a member of the Beta Gamma Sigma Honor Society. She completed her undergraduate studies in Biochemistry at Fudan University in China.

Positions